Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Will Shire agree to extend Takeda takeover talks?

UK rules mean Shire must agree to extend deadline

AstraZeneca AZ

AZ’s immuno-oncology combo fails another lung cancer trial

Latest failure casts doubt on company’s CTLA4 drug

- PMLiVE

Sanofi appoints ex-Roche Reed as new R&D head

John Reed to take up post after leaving Roche last month

- PMLiVE

FDA panel undermines Lilly and Incyte’s baricitinib hopes

Mixed review doesn’t bode well in competitive market

- PMLiVE

Why can’t we use Google Maps to understand patient journeys?

Patient experiences are diverse and dynamic. Mapping patient journeys enables us to unlock salient insights and redesign care pathways.

Porterhouse Medical Group

- PMLiVE

Tech-giants allegedly interested in Nokia’s digital health unit

Both Samsung and Google’s Nest could be gearing up for a takeover bid

- PMLiVE

McCann Health launch scientific council

The new initiative becomes the first-of-its kind in the healthcare comms industry

- PMLiVE

Accretio appoints Neil Levinson as strategy director

He joins the healthcare consultancy from Kaiser Associates

- PMLiVE

New centre aims to Catapult UK into cell and gene therapy lead

The UK is hoping to cement its lead as a world leader in cell and gene therapy manufacturing thanks to a new ‘Catapult’ centre opened today.

- PMLiVE

Merck preps regulatory filings for much-needed antibiotic combo

The regimen combines Merck’s own Primaxin with new beta lactamase inhibitor relebactam

- PMLiVE

Data integrity scuppers Fresenius deal with Akorn

However Fresenius could be liable to pay $129m in termination fees

- PMLiVE

Relay Therapeutics strengthens team

Don Bergstorm, Brian Adams and Tom Catinazzo join the biotech

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links